Amyl Therapeutics — Société à responsabilité limitée in Liège
Amyl Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises (KBO/BCE) under number 0758.775.372. Incorporated as a Société à responsabilité limitée, it is currently Active, with its registered office located in Liège. According to official KBO/BCE records, the company was registered on 26 November 2020. This page consolidates all publicly available information: address, directors, main economic activity, branches and tax identifiers.
Company identity
- KBO/BCE number: 0758.775.372
- VAT number: BE 0758.775.372
- Entity type: Personne morale
- Legal form: Société à responsabilité limitée
- Status: Active
- Start date: 26 November 2020
Registered office address
The registered office of Amyl Therapeutics is located at: Boulevard de Patience et Beaujonc 3, 4000 Liège. This address corresponds to the principal place of business declared with the Crossroads Bank for Enterprises and is used for all official correspondence.
Main activity
The main economic activity declared by Amyl Therapeutics is: Recherche-développement en biotechnologie (NACE-BEL code 72101). This activity is listed in the official NACE classification used by Belgian and European authorities to categorise economic sectors.
Peppol e-invoicing
Peppol identifier of Amyl Therapeutics: 0208:0758775372. This identifier allows the sending and receiving of electronic invoices (e-invoicing) over the Peppol network, in compliance with Belgian B2B invoicing regulations.
Active branches
Amyl Therapeutics currently has 1 active branch(es) declared with the KBO/BCE, in addition to its registered office. The full list of branches with details is available further down on this page.
Data updated on 07 April 2026 (source: KBO/BCE).